vaccinations < vaccine < vaccines

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000064 (2020-04-21)	Cécile Khou [France] ; Marco Aurelio Díaz-Salinas [France] ; Anaelle Da Costa [France] ; Christophe Préhaud [France] ; Patricia Jeannin [France] ; Philippe V. Afonso [France] ; Marco Vignuzzi [France] ; Monique Lafon [France] ; Nathalie Pardigon [France]	Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine strains in an in cellulo model of human blood-brain barrier
000095 (2020-04-06)	R. Djidjou-Demasse [France] ; Y. Michalakis ; M. Choisy ; M. T. Sofonea ; S. Alizon	Optimal COVID-19 epidemic control until vaccine deployment
000178 (2019)	Cindy Bernelin-Cottet [France] ; Celine Urien [France] ; Joanne Mccaffrey [Irlande (pays)] ; Damien Collins [Irlande (pays)] ; Agnese Donadei [Irlande (pays)] ; Dennis Mcdaid [Irlande (pays)] ; Virginie Jakob [Suisse] ; Christophe Barnier-Quer [Suisse] ; Nicolas Collin [Suisse] ; Edwige Bouguyon [France] ; Elise Bordet [France] ; Céline Barc [France] ; Olivier Boulesteix [France] ; Jean Jacques Leplat [France] ; Fany Blanc [France] ; Vanessa Contreras [France] ; Nicolas Bertho [France] ; Anne C. Moore [Irlande (pays)] ; Isabelle Schwartz-Cornil [France]	Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs
000184 (2019)	Laurence Torcel-Pagnon [France] ; Vincent Bauchau [Belgique] ; Patrick Mahy [Belgique] ; Myint Tin Tin Htar [France] ; Marianne Van Der Sande [Pays-Bas] ; Cédric Mahé [France] ; Tyra Grove Krause [Danemark] ; Anne Charrat [France] ; François Simondon [France] ; Xavier Kurz [Royaume-Uni]	Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
000212 (2018-03)	V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]	Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000219 (2018)	Pierre Verger [France] ; Lisa Fressard ; Sebastien Cortaredona [France] ; Daniel Levy-Bruhl ; Pierre Loulergue ; Florence Galtier [France] ; Aurelie Bocquier [France]	Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza A(H1N1) pandemic
000247 (2017-10)	Cécile Souty [France] ; Ana-Maria Vilcu [France] ; Lisandru Capai [France] ; Sylvie Van Der Werf [France] ; Martine Valette [France] ; Thierry Blanchon [France] ; Bruno Lina [France] ; Sylvie Behillil [France] ; Thomas Hanslik [France] ; Alessandra Falchi [France]	Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France
000280 (2017)	A. Palache [Pays-Bas] ; A. Abelin [France] ; R. Hollingsworth [France] ; W. Cracknell [Australie] ; C. Jacobs [Belgique] ; T. Tsai [États-Unis] ; P. Barbosa [Suisse]	Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
000313 (2016-07)	Aurelien Jamotte ; Chui Fung Chong ; Andrew Manton ; Berengere Macabeo ; Mondher Toumi [France]	Impact of quadrivalent influenza vaccine on public health and ă influenza-related costs in Australia
000337 (2016)	Cindy Bernelin-Cottet [France] ; Charlotte Deloizy [France] ; Ondrej Stanek [République tchèque] ; Céline Barc [France] ; Edwige Bouguyon [France] ; Celine Urien [France] ; Olivier Boulesteix [France] ; Jérémy Pezant [France] ; Charles-Adrien Richard [France] ; Mohammed Moudjou [France] ; Bruno Da Costa [France] ; Luc Jouneau [France] ; Christophe Chevalier [France] ; Claude Leclerc [France] ; Peter Sebo [République tchèque] ; Nicolas Bertho [France] ; Isabelle Schwartz [France]	A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies
000338 (2016)	Scott Preiss [Belgique] ; Nathalie Garçon [France] ; Anthony L. Cunningham [Australie] ; Richard Strugnell [Australie] ; Leonard R. Friedland [États-Unis]	Vaccine provision: Delivering sustained & widespread use.
000384 (2015)	Pierre-Louis Hervé [France] ; Valérie Lorin [France] ; Grégory Jouvion [France] ; Bruno Da Costa [France] ; Nicolas Escriou [France]	Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity
000387 (2015)	Julie Medina [France] ; Houda Boukhebza [France] ; Amélie De Saint Jean [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France] ; Catherine Moste [France]	Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
000393 (2015)	Blandine Rougemont [France] ; Romain Simon [France] ; Romain Carrière [France] ; Jordane Biarc [France] ; Catherine Fonbonne [France] ; Arnaud Salvador [France] ; Céline Huillet [France] ; Yves Berard [France] ; Olivier Adam [France] ; Catherine Manin [France] ; Jérôme Lemoine [France]	Absolute quantification of dengue virus serotype 4 chimera vaccine candidate in Vero cell culture by targeted mass spectrometry
000455 (2014)	O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France]	Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis
000458 (2014)	Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France]	Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
000468 (2013-11-30)	Emily Loison [France] ; Béatrice Poirier-Beaudouin [France] ; Valérie Seffer [France] ; Audrey Paoletti [France] ; Vered Abitbol [France] ; Eric Tartour [France] ; Odile Launay [France] ; Marie-Lise Gougeon [France]	Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cells.
000500 (2013)	Mariette Ducatez [France] ; Ashley Webb [Swaziland] ; Jeri-Carol Crumpton [Swaziland] ; Richard J. Webby [Swaziland]	Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model
000506 (2013)	R. G. Pebody ; N. Andrews ; D. M. Fleming ; J. Mcmenamin ; S. Cottrell ; B. Smyth ; H. Durnall ; C. Robertson [France] ; W. Carman ; J. Ellis ; P. Sebastian-Pillai ; M. Zambon ; C. Kearns ; C. Moore ; D. R. Thomas ; J. M. Watson	Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom
000538 (2013)	Carlos A. Diazgranados [États-Unis] ; Andrew J. Dunning [États-Unis] ; Emilia Jordanov [États-Unis] ; Victoria Landolfi [États-Unis] ; Martine Denis [France] ; H. Keipp Talbot [États-Unis]	High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season
000544 (2013)	R. G. Pebody [Royaume-Uni] ; N. Andrews [Royaume-Uni] ; D. M. Fleming [Royaume-Uni] ; J. Mcmenamin [Royaume-Uni] ; S. Cottrell [Royaume-Uni] ; B. Smyth [Royaume-Uni] ; H. Durnall [Royaume-Uni] ; C. Robertson [Royaume-Uni, France] ; W. Carman [Royaume-Uni] ; J. Ellis [Royaume-Uni] ; P. Sebastian-Pillai [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; C. Kearns [Royaume-Uni] ; C. Moore [Royaume-Uni] ; D. Rh. Thomas [Royaume-Uni] ; J. M. Watson [Royaume-Uni]	Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i -k "vaccine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i  \
                -Sk "vaccine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    vaccine
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021